(Q37883710)

24 August 2017

1 reference

title

Non-PKU mild hyperphenylalaninemia (MHP)--the dilemma (English)

1 reference

24 August 2017

main subject

hyperphenylalaninemia

1 reference

W B Hanley

1

1 reference

24 August 2017

language of work or name

1 reference

14 May 2011

1 reference

Molecular Genetics and Metabolism

24 August 2017

published in

1 reference

24 August 2017

volume

104

1 reference

24 August 2017

issue

1-2

1 reference

24 August 2017

page(s)

23-26

1 reference

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Neuropsychology of early-treated phenylketonuria: specific executive function deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Psychosocial aspects of PKU: hidden disabilities--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Psychiatric symptoms and disorders in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Persistent mild hyperphenylalaninemia in the untreated state. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Neuropsychological function in mild hyperphenylalaninemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Sustained attention in untreated non-PKU-hyperphenylalaninemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Intelligence and quality of dietary treatment in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Stability of blood phenylalanine levels and IQ in children with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Neonatal screening in Europe; the situation in 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Molecular basis of mild hyperphenylalaninaemia in Poland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Selective screening of amino acid disorders in the south-west of Iran, Shiraz

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Intelligence in mild atypical phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Maternal mild hyperphenylalaninaemia: an international survey of offspring outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

Mild hyperphenylalaninemia: to treat or not to treat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.05.007

10.1016/J.YMGME.2011.05.007

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference